LoL: Gen.G Global Academy vs Hanwha Life Esports Challengers (BO3) - LCK Challengers League Rounds 3-4 Trial Group
- Game 1 Winner
- 100%
- +68.5
- O/U 2.5 Games
- 100%
- +56.0
- Both Teams Slay a Dragon
- 100%
- +40.0
- Both Teams Slay a Dragon
- 100%
- +40.0
- Both Teams Slay a Dragon
- 100%
- +49.5
- Any Player Quadra Kill
- 50%
- —
- Any Player Penta Kill
- 50%
- —
- Any Player Quadra Kill
- 50%
- —
- Any Player Penta Kill
- 50%
- —
- Any Player Quadra Kill
- 50%
- —
- Any Player Penta Kill
- 50%
- —
- Game 2 Winner
- 0%
- −31.9
- Match Winner
- 0%
- −24.9
- Game Handicap: HLE (-1.5) vs Gen.G Global Academy (+1.5)
- 0%
- −45.5
- Both Teams Slay Baron Nashor
- 0%
- −40.0
- Both Teams Destroy Inhibitors
- 0%
- −40.0
- Odd/Even Total Kills
- 0%
- −40.0
- Both Teams Slay Baron Nashor
- 0%
- −40.0
- Both Teams Destroy Inhibitors
- 0%
- −40.0
- Odd/Even Total Kills
- 0%
- −40.0
- Both Teams Slay Baron Nashor
- 0%
- −49.5
- Both Teams Destroy Inhibitors
- 0%
- −49.5
- Odd/Even Total Kills
- 0%
- −49.5
Traders currently price "Game 1 Winner" at 100% for "LoL: Gen.G Global Academy vs Hanwha Life Esports Challengers (BO3) - LCK Challengers League Rounds 3-4 Trial Group". Over the past 24 hours that probability moved up 68.5 points. Full distribution: Game 1 Winner 100%, O/U 2.5 Games 100%, Both Teams Slay a Dragon 100%, Both Teams Slay a Dragon 100%. The market has traded $664K in total volume and resolves Aug 4, 2026. Gen.G Global Academy enters this LCK Challengers League BO3 with the edge of superior organizational resources and a deeper talent pipeline from its LCK parent squad, often translating to stronger mid-game macro and coordinated teamfights. Hanwha Life Esports Challengers has posted mixed Trial Group results in Rounds 3-4, with recent losses highlighting inconsistencies in early-game aggression and objective control. Head-to-head history shows competitive series, but Gen.G's recent form and patch 26.15 adaptations in the bot lane and jungle have pressured HLE's defensive setups. Roster stability and individual carry potential remain the decisive variables in this Trial Group matchup.
Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.